NCI Drug Dictionary
The NCI Drug Dictionary contains technical definitions and synonyms for drugs/agents used to treat patients with cancer or conditions related to cancer. Each drug entry includes links to check for clinical trials listed in NCI's List of Cancer Clinical Trials.
- gataparsen sodium
A second-generation antisense oligonucleotide directed against survivin mRNA with potential antitumor activity. Gataparsen sodium hybridizes to survivin mRNA, thereby blocking translation of survivin protein, a member of the inhibitor of apoptosis (IAP) family. Silencing the expression of survivin may result in the restoration of the apoptotic process in tumor cells, facilitating chemotherapeutic treatment. Survivin, expressed during embryonal development, is upregulated in a variety of human cancers while absent in most normal adult cells; its expression in tumors is associated with a more aggressive phenotype, shorter survival times, and a decreased response to chemotherapy. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonym: antisurvivin antisense oligonucleotide LY2181308 Code name: LY2181308